Role of Cariprazine in Managing and Preventing Refractory Catatonia: A Case Study.

This case study explores the management of a 22-year-old male patient diagnosed with recurrent refractory catatonia, a neuropsychiatric condition characterized by motor, behavioral, and autonomic disturbances often associated with bipolar disorder. Despite comprehensive investigations, including normal results in tests such as complete blood count (CBC), liver function tests (LFT), thyroid function tests (TFT), renal function tests (RFT), C-reactive protein (CRP), creatine kinase (CKP), and serum electrolytes, the patient's condition persisted. Initial treatments with conventional therapies, such as benzodiazepines, proved unsuccessful. However, the introduction of cariprazine, an atypical antipsychotic, combined with electroconvulsive therapy (ECT), resulted in significant improvement. This case highlights the challenges of managing treatment-resistant catatonia and suggests cariprazine's potential role in preventing catatonic relapses when other therapies fail. The patient's sustained remission underscores the need for further investigation into cariprazine as a viable option for refractory cases.
Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
(Copyright © 2024, Qasab et al.)